PHARMACOGENOMICS ANALYSIS LABORATORY Cooperative Studies Program (CSP) Office of Research & Development, Department of Veterans Affairs Central Arkansas Veterans Healthcare System (CAVHS) Little Rock, AR CSP ORGANIZATION VETERANS HEALTH ADMIN Office of Research & Development Biomedical Laboratory R&D Clinical Science R&D Health Services R&D Rehabilitation R&D Cooperative Studies Program Pharmacogenomics Analysis Laboratory (PAL) CSP MISSION To advance the health and care of Veterans through collaborative research studies that produce innovative and effective solutions to national healthcare problems. CSP OVERVIEW • CSP is a national infrastructure for sponsoring, developing & executing: Multi-site clinical trials Epidemiological & population research Genomics research • First Cooperative Study conducted in 1940s on streptomycin for treating tuberculosis in WWII veterans Program formally established in 1972 • Over 175 clinical trials and observational studies completed including landmark studies in cardiovascular disease / cardiovascular surgery, infectious diseases, surgery, gastroenterology, mental health, oncology, and endocrinology. CSP CENTER LOCATIONS Seattle, WA Boston, MA West Haven, CT Hines, IL Palo Alto, CA Little Rock, AR Albuquerque, NM Perry Point, MD Washington, DC Durham, NC VA Genomic Medicine Program • In 2006, the Department of Veterans Affairs launched the Genomic Medicine Program: to examine the potential of emerging genomic technologies to optimize medical care for veterans to enhance the development of tests and treatments for relevant diseases Genomic Medicine Program Con’t • Genomic Medicine Program Advisory Committee • Veterans’ Consultation Project 83% supported; 71% willing to participate • Scientific Projects Investigator-initiated Large scale cohorts (SMI, PTSD, ALS) Million Veteran Program (non-disease based) Infrastructure Development Expansion of Biorepository IT and Informatics CSP DNA Bank (~30,000 samples) Expansion to ~4M; robotic store; automation Genomic Information System for Integrated Sciences(GenISIS) Pharmacogenomics Laboratory (PAL) Established in 2007 Pharmacogenomics Analysis Laboratory (PAL) •CLIA88 approved laboratory with capacity to conduct medium to high throughput genotyping and gene expression assays. •Support ongoing and future pharmacogenomics observational studies and clinical trials. •Improving treatment of most illnesses by reducing toxicity and increasing efficacy of drugs by facilitating optimal treatment selection, appropriate dose individualization, and drug discovery. PAL Organizational FlowChart DIRECTOR Steven A. Schichman, M.D., Ph.D. LABORATORY MANAGER Angie Stone, B.S. Weleetka Carter, Maria Winters, Angie Stone Dr. Steven A. Schichman PAL Director PROJECT MANAGER Maria Winters, M.P.H. PROJECT COORDINATOR Weleetka Carter, B.S. Gene Expression RNA Purification & Quantification NanoDrop UV/Vis, Agilent Bioanalyzer, Biotek Plate Reader (RiboGreen Fluorescence) TaqMan RNAse P ABI Taqman, Illumina iScan & BeadXpress miRNA miRNA ABI Taqman SNP Genotyping DNA Purification & Quantification NanoDrop UV/Vis, Agilent Bioanalyzer, Biotek Plate Reader (PicoGreen Fluorescence) TaqMan RNAse P Protein Quantification PAL Data Analysis & Final Reports ABI Taqman, Illumina iScan & BeadXpress Copy Number, EpiGenetic Events ABI Taqman, Illumina iScan & BeadXpress Protein Analysis NanoDrop UV/Vis, Agilent Bioanalyzer Illumina BeadXpress CAVHS ABI 7900HT TaqMan System The ABI 7900HT (Applied Biosystems, Inc., Foster City, CA) is a PCR-based, real-time thermal cycling instrument with fluorescence detection for low-tomoderate throughput genotyping and gene expression Applications Supported by ABI7900HT TaqMan Genotyping by Allelic Discrimination Gene Expression Real-Time Quantification Copy Number Variation Illumina iScan System •iScan microarray scanner (Illumina, Inc., San Diego, CA) is a confocal laser scanner with dual fluorescent channels for imaging Illumina’s array-based genetic analysis products. •Automation with the AutoLoader2 provides high-throughput scanning. iScan Applications Copy Number Variation: Discovery and Analysis BeadChip Genotyping Array: Whole-Genome SNP Analyses, Cytogenetic Analysis, Linkage Profiling Gene Expression Treatment_ AVG_Signal 30000 20000 10000 0 0 10000 20000 30000 Cont rol_AVG_Signal Whole-Genome Expression Profiling, Differential Gene Expression, microRNA profiling Whole-Genome Methylation Analyses, Differential Methylation, Dendrograms (Cluster Analysis) Illumina iScan Array Products Illumina BeadXpress System Illumina’s BeadXpress Reader is a dual-color laser detection system for custom low- to mid-plex genotyping, methylation analysis, SNP detection and protein screening. ADME Core Panel for Pharmacogenetic Genotyping Investigate genetic associations to drug • Response • Dosing • Safety ► Personalized Medicine ► *Absorption, Distribution, Metabolism, and Excretion VeraCode ADME Core Panel ADME Core (34 genes, 184 markers) ABCB1 CYP2C9 NAT1 SULT1A1 ABCC2 CYP2D6 NAT2 TPMT ABCG2 CYP2E1 SLC15A2 UGT1A1 CYP1A1 CYP3A4 SLC22A1 UGT2B15 CYP1A2 CYP3A5 SLC22A2 UGT2B17 CYP2A6 DPYD SLC22A6 UGT2B7 CYP2B6 GSTM1 SLCO1B1 VKORC1 CYP2C19 GSTP1 SLCO1B3 CYP2C8 GSTT1 SLCO2B1 >95% Pharma ADME Core List: www.pharmaadme.org IT Requirements • Large capacity Terabyte Servers • 64-Bit Computers • GenomeStudio Software Suite • Statistical Discovery Software CSP Study Update CSP 500b: Genetic Epidemiology of Amyotrophic Lateral Sclerosis (ALS) • GWAS analysis by Affymetrix & Illumina platforms completed • • 1200 ALS patients ; 400 Controls Analysis of data ongoing at the Durham VA and Duke University Principal Investigators in CSP500b: Durham VAMC and Duke University Medical Center, NC Eugene Z. Oddone, M.D., M.H.S. Silke Schmidt, Ph.D. Dawn Provenzale, M.D., M.S. Michael A. Hauser, Ph.D. Boston MAVERIC and Tissue Core Biorepository, MA Mary Brophy, M.D. Donald E. Humphries, Ph.D. Durham VA Medical Center North Carolina Summary • PAL serves as a national VA resource for various molecular, genetic and genomic analyses (low to high throughput) • Isolation to data analysis • CLIA certified